Special Issue "Updates on Novel Antimicrobial Agents and Strategies Against Pathogenic Bacteria"
Deadline for manuscript submissions: closed (30 September 2019).
Interests: antibiotic resistance mechanisms; genetic bases for the diffusion of antibiotic resistance genes; microbial bioinformatics; new antimicrobial drugs; bacteriophages; bacteriophages as tools for phage therapy
Special Issues and Collections in MDPI journals
Special Issue in Antibiotics: Antibiotics and Antibiotic Resistance in Aquatic Environments
Special Issue in Antibiotics: Updates on Novel Antimicrobials Agents and Strategies Against Pathogenic Bacteria, 2nd Edition
The problem of antibiotic resistance in bacterial pathogens has reached alarming levels, with the emergence and diffusion at worldwide scale of strains displaying complex antibiotic resistance phenotypes which seriously impede the effective treatment of some bacterial infections. A number of international bodies, such as the World Health Organization and the American Center for Disease Control and Prevention, forecast that this ‘antibiotic resistance crisis’ will lead to the death of several million people per year in the 21th century. Therefore, there is an urgent need to develop novel antibiotics and innovative antimicrobial approaches to avoid the return to the “pre-antibiotic era”.
This Special Issue aims to provide an update about original approaches to fight bacterial pathogens. It is expected that this Special Issue will collect research articles on new molecules with antimicrobial activity, including new conventional antibiotics of either synthetic or natural origin, modified drugs with augmented potency to be used alone or in synergy, innovative alternatives such bacteriophages or components thereof, enzybiotics, and probiotics able to displace the pathogenic microflora.
Dr. Marco Maria D'Andrea
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial drugs
- new antimicrobials